Anaplastic Large Cell (Ki-1 / CD-30) Lymphoma

Anaplastic large cell lymphoma (ALCL) is a rare form of indolent (slow growing) Non-Hodgkin’s Lymphoma (NHL) that affects T-cells. It accounts for 1 in 50 cases of NHL and is more common in children and men. This cancer often affects the lymph nodes, skin, liver, lungs, and bone marrow.

This disease can be systematic (occurring throughout the body) or cutaneous (occurring in or on the skin).

Diagnosis and Staging

ALCL presents with typical lymphoma symptoms, including swollen, painless lymph nodes, night sweats, fever, weight loss, and fatigue.

Diagnosis is made via lymph node biopsy. Other test, such as CT scans, PET scans, ultrasounds, and chest X-rays are used for staging. The stages are as follows:

Stage I
Cancerous cells are found in only one lymph node group or one area outside of the lymphatic system
Stage II
Two lymph groups are affected on the same side of the diaphragm, or one lymph group and a nearby organ are affected.
Stage III
Lymph groups on both sides of the diaphragm are involved. Lymph cells may also have moved to one internal organ, such as the liver or lungs. Cells may also have metastasized to the spleen.
Stage IV
More than one organ is involved. Bone marrow may also be affected.

Treatment

Treatments vary depending on the stage of the disease and may include one or more of the following:

  • Chemotherapy, especially the CHOP regimen
  • Radiation is given for the earlier stages of disease, or in combination with chemotherapy for later stages of the disease.
  • Stem cell transplant/bone marrow transplant is used in very advanced cases.

Related Articles

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap